These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 33096451

  • 21. L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of β-catenin-mutated human hepatocellular carcinoma cells.
    Tardito S, Chiu M, Uggeri J, Zerbini A, Da Ros F, Dall'Asta V, Missale G, Bussolati O.
    Curr Cancer Drug Targets; 2011 Oct; 11(8):929-43. PubMed ID: 21834755
    [Abstract] [Full Text] [Related]

  • 22. Autophagic flux modulation by Wnt/β-catenin pathway inhibition in hepatocellular carcinoma.
    Turcios L, Chacon E, Garcia C, Eman P, Cornea V, Jiang J, Spear B, Liu C, Watt DS, Marti F, Gedaly R.
    PLoS One; 2019 Oct; 14(2):e0212538. PubMed ID: 30794613
    [Abstract] [Full Text] [Related]

  • 23. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
    Kwon S, Jeon JS, Ahn C, Sung JS, Choi I.
    Biochem Biophys Res Commun; 2016 Oct 07; 479(1):74-9. PubMed ID: 27616194
    [Abstract] [Full Text] [Related]

  • 24. Cytotoxic Effect of Bromelain on HepG2 Hepatocellular Carcinoma Cell Line.
    Murthy SS, Narsaiah TB.
    Appl Biochem Biotechnol; 2021 Jun 07; 193(6):1873-1897. PubMed ID: 33735410
    [Abstract] [Full Text] [Related]

  • 25. Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy.
    Yang Z, Zhao T, Liu H, Zhang L.
    Sci Rep; 2016 Jan 19; 6():19383. PubMed ID: 26783250
    [Abstract] [Full Text] [Related]

  • 26. Antiproliferative and Apoptotic Effects of Cardamonin against Hepatocellular Carcinoma HepG2 Cells.
    Badroon NA, Abdul Majid N, Alshawsh MA.
    Nutrients; 2020 Jun 12; 12(6):. PubMed ID: 32545423
    [Abstract] [Full Text] [Related]

  • 27. PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK/mTOR/ULK1 signaling pathway.
    Zhang J, Wang E, Zhang L, Zhou B.
    Cell Biol Int; 2021 Feb 12; 45(2):305-319. PubMed ID: 33079432
    [Abstract] [Full Text] [Related]

  • 28. [Matrine suppresses stemness of hepatocellular carcinoma cells by regulating β-catenin signaling pathway].
    Dai M, Cai Z, Chen N, Li J, Wen J, Tan L, Guo D.
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct 30; 39(10):1239-1245. PubMed ID: 31801708
    [Abstract] [Full Text] [Related]

  • 29. Tanshindiol-C suppresses in vitro and in vivo hepatocellular cancer cell growth by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of angiogenesis and modulation of key tumor-suppressive miRNAs.
    Zhou P, Cheng Y, Liu F, Wu K, Qiu W, Wang S.
    J BUON; 2019 Oct 30; 24(2):622-627. PubMed ID: 31128015
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH, Feng WC, Lu LC, Shao YY, Hsu CH, Cheng AL.
    Cancer Lett; 2016 Oct 10; 381(1):58-66. PubMed ID: 27431312
    [Abstract] [Full Text] [Related]

  • 31. An oral 2-hydroxypropyl-β-cyclodextrin-loaded spirooxindole-pyrrolizidine derivative restores p53 activity via targeting MDM2 and JNK1/2 in hepatocellular carcinoma.
    Gao X, Wei M, Shan W, Liu Q, Gao J, Liu Y, Zhu S, Yao H.
    Pharmacol Res; 2019 Oct 10; 148():104400. PubMed ID: 31425749
    [Abstract] [Full Text] [Related]

  • 32. Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing DNA damage-dependent cell cycle arrest.
    Li QZ, Chen YY, Liu QP, Feng ZH, Zhang L, Zhang H.
    Phytomedicine; 2024 Apr 10; 126():155177. PubMed ID: 38412667
    [Abstract] [Full Text] [Related]

  • 33. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C.
    Carcinogenesis; 2013 Jun 10; 34(6):1323-30. PubMed ID: 23404993
    [Abstract] [Full Text] [Related]

  • 34. Dalbinol, a rotenoid from Amorpha fruticosa L., exerts anti-proliferative activity by facilitating β-catenin degradation in hepatocellular carcinoma cells.
    Zhu X, Wu X, Cheng J, Liao H, Di X, Li L, Li R, Zhou Y, Zhang X.
    Oncotarget; 2017 Jul 18; 8(29):47755-47766. PubMed ID: 28548956
    [Abstract] [Full Text] [Related]

  • 35. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
    Tan HY, Wang N, Li S, Hong M, Guo W, Man K, Cheng CS, Chen Z, Feng Y.
    Cell Physiol Biochem; 2018 Jul 18; 47(5):1819-1834. PubMed ID: 29953980
    [Abstract] [Full Text] [Related]

  • 36. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L, Li M, Liu D, Wang X, Wang P, Dai H, Yang W, Liu W, Hu X, Zhao M.
    Molecules; 2019 Jan 22; 24(3):. PubMed ID: 30678274
    [Abstract] [Full Text] [Related]

  • 37. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S, Xiong M, Zhan DQ, Liang BY, Wang YY, Gutmann DH, Huang ZY, Chen XP.
    Carcinogenesis; 2012 Mar 22; 33(3):538-47. PubMed ID: 22226916
    [Abstract] [Full Text] [Related]

  • 38. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma.
    Hu P, Ke C, Guo X, Ren P, Tong Y, Luo S, He Y, Wei Z, Cheng B, Li R, Luo J, Meng Z.
    Dig Liver Dis; 2019 Jan 22; 51(1):120-126. PubMed ID: 30001951
    [Abstract] [Full Text] [Related]

  • 39. Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways.
    Cheng Z, Yuan X, Qu Y, Li X, Wu G, Li C, Zu X, Yang N, Ke X, Zhou J, Xie N, Xu X, Liu S, Shen Y, Li H, Zhang W.
    Cancer Lett; 2017 Sep 10; 403():195-205. PubMed ID: 28645563
    [Abstract] [Full Text] [Related]

  • 40. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.
    Dai XY, Zeng XX, Peng F, Han YY, Lin HJ, Xu YZ, Zhou T, Xie G, Deng Y, Mao YQ, Yu LT, Yang L, Zhao YL.
    Cell Physiol Biochem; 2012 Sep 10; 29(1-2):281-90. PubMed ID: 22415097
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.